STATE STREET CORP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$126,745,792
+21.2%
2,505,848
+11.9%
0.01%
+40.0%
Q2 2023$104,596,385
+22.5%
2,240,231
+0.4%
0.01%0.0%
Q1 2023$85,350,676
-68.9%
2,230,807
-55.4%
0.01%
-37.5%
Q4 2022$274,106,202
+1370.0%
5,001,938
+813.4%
0.01%
+700.0%
Q3 2022$18,647,000
+300.4%
547,622
+11.1%
0.00%
Q2 2022$4,657,000
-73.5%
492,852
-60.2%
0.00%
-100.0%
Q1 2022$17,583,000
-19.5%
1,239,117
+20.0%
0.00%0.0%
Q4 2021$21,840,000
-15.3%
1,032,621
-10.5%
0.00%0.0%
Q3 2021$25,794,000
-15.4%
1,154,101
-6.1%
0.00%
-50.0%
Q2 2021$30,495,000
+11.8%
1,229,140
+30.8%
0.00%0.0%
Q1 2021$27,271,000
+27.7%
940,046
+13.5%
0.00%
+100.0%
Q4 2020$21,359,000
+218.8%
827,884
+280.4%
0.00%
Q3 2020$6,700,000
+43.3%
217,613
+16.0%
0.00%
Q2 2020$4,675,000
+85.7%
187,590
+57.9%
0.00%
Q1 2020$2,518,000
+28.9%
118,784
+35.0%
0.00%
Q4 2019$1,953,000
+23.6%
88,014
+26.7%
0.00%
Q3 2019$1,580,00069,4540.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders